Science & Innovation

Pipeline

Dorzagliatin

mGluR5

Poster and Presentation

Peer Reviewed Publications

Announcements and Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock Information

Corporate Communications

Portfolio Advisory Board

Senior Scientific Advisory Board

Our Science

> Our Science

> Poster and Presentation

Poster and Presentation

Peer Reviewed Publications

Poster and Presentation

2022 ADA Poster

Dorzagliatin, a dual-acting glucokinase activator, improves insulin secretion and glucose sensitivity in glucokinase-maturity-onset diabetes of the young (GK-MODY) and recent-onset type 2 diabetes.

2022 ADA Poster

Glucokinase Activator Restore Glucose Sensitivity and Early Phase Insulin Secretion in T2DM Patients: A Post-hoc Analysis of the Phase III Trials of Dorzagliatin.

2022 ADA Poster

Dorzagliatin Effect in Diabetes Remission (DREAM Study)

2021 ADA Poster

Glucokinase Activator Dorzagliatin (HMS5552) Regulates GLP1 Release in T2D Patients and is Synergistic with Sitagliptin and Empagliflozin in Optimizing Beta Cell Function.

2021 ADA Poster

Dorzagliatin as a Glucose Sensitizer Achieved Sustained Glycemic Control in Combination with Metformin in Chinese T2DM Patients in a 52-Week Phase 3 Clinical Trial (DAWN Study)

2020 ADA Poster

Dorzagliatin as a Glucose Sensitizer Achieved Sustained Glycemic Control in Drug-Na?ve T2D Patients in a 52-Week Phase 3 Monotherapy Trial (SEED Study)

About Us

Company Overview

Company History

Leadership Team

Portfolio Advisory Board

Senior Scientific Advisory Board

Partner

Media center

Research & Development

Inovation

Pipeline

Dorzagliatin

mGluR5

Company Publications

Peer Reviewed Publications

Investor Relations

Corporate Governance

Financial Report

Announcements & Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock information

Media

Company News

Media Releases

Video

Careers

Culture

Join Us

Product

HuaTangNing(華堂寧?)

Focus Us

Copyright ? 2024 Hua Medicine (Shanghai) Co., Ltd. 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號(hào): （滬）-非經(jīng)營-2022-0079
滬ICP備14036654號(hào)-1

滬公網(wǎng)安備 31011502013809號(hào) Privacy Statement Terms of Use

How we use cookies

Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.